Dr. Axel DERWA, inwendige geneeskunde
0886.911.976 · rovalta.com · 27/09/2026
ACTIVE
Dr. Axel DERWA, inwendige geneeskunde
Financial year 2025 · Closed on 31/12/2025
Net result181,7 k €+57,9 %over 1 year
Gross margin281,2 k €+55,4 %over 1 year
Equity699,5 k €+4,1 %over 1 year
Overview
Identity
Source · BCE/KBODr. Axel DERWA, inwendige geneeskunde is a Private limited company incorporated in 2007. Its registered office is in Lubbeek.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0886.911.976
- Incorporation
- 22/01/2007
- Legal form
- Private limited company
- Registered office
- Konijnenpijp(LIN) 4
3210 Lubbeek · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 20 filingsTrend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 281,2 k € | +55.4% | 181 k € | -2.9% | 186,4 k € | +58.2% | 117,8 k € | -30.7% | 170 k € |
| EBITDA | 278,8 k € | +55.8% | 178,9 k € | -2.8% | 184,2 k € | +57.9% | 116,6 k € | -30.7% | 168,3 k € |
| Operating result | 264,5 k € | +56.5% | 169 k € | -3.5% | 175,1 k € | +66.8% | 105 k € | -28.5% | 147 k € |
| Net result | 181,7 k € | +57.9% | 115,1 k € | -7.3% | 124,1 k € | +46.5% | 84,7 k € | -22.6% | 109,5 k € |
| Balance sheet | |||||||||
| Equity | 699,5 k € | +4.1% | 672,2 k € | -14.5% | 786,5 k € | +18.7% | 662,3 k € | 0.0% | 662,3 k € |
| Total assets | 789,1 k € | -3.7% | 819,5 k € | -13.7% | 949,7 k € | +6.8% | 889 k € | +2.6% | 866,2 k € |
| Cash | 141,2 k € | +52.3% | 92,7 k € | +25.7% | 73,7 k € | -74.1% | 284,2 k € | +0.2% | 283,5 k € |
| Debts | 88,5 k € | -39.8% | 146,9 k € | +6.4% | 138,1 k € | -38.9% | 226,1 k € | +10.9% | 203,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Axel Derwa | Director |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Axel Derwa | Manager |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2026 | 31/07/2025 | 31/07/2024 | 29/09/2023 | 24/08/2022 | 01/09/2021 |
| General meeting | 09/06/2026 | 10/06/2025 | 11/06/2024 | 13/06/2023 | 14/06/2022 | 08/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 20 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 09/06/2026 | 31/08/2026 | Dutch | |
| Micro model | 31/12/2024 | 10/06/2025 | 31/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 11/06/2024 | 31/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 13/06/2023 | 29/09/2023 | Dutch | |
| Micro model | 31/12/2021 | 14/06/2022 | 24/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 08/06/2021 | 01/09/2021 | Dutch | |
| Micro model | 31/12/2019 | 09/06/2020 | 31/08/2020 | Dutch | |
| Micro model | 31/12/2018 | 11/06/2019 | 30/09/2019 | Dutch | |
| Micro modelCorrection | 31/12/2017 | 12/06/2018 | 01/10/2018 | Dutch | |
| Micro model | 31/12/2017 | 12/06/2018 | 31/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 13/06/2017 | 29/09/2017 | Dutch | |
| Abridged model | 31/12/2015 | 14/06/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 09/06/2015 | 30/09/2015 | Dutch | |
| Abridged model | 31/12/2013 | 01/07/2014 | 28/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 11/06/2013 | 30/09/2013 | Dutch | |
| Abridged model | 31/12/2011 | 12/06/2012 | 21/12/2012 | Dutch | |
| Abridged model | 31/12/2010 | 14/06/2011 | 31/08/2011 | Dutch | |
| Abridged model | 31/12/2009 | 08/06/2010 | 31/08/2010 | Dutch | |
| Abridged model | 31/12/2008 | 05/05/2009 | 11/08/2009 | Dutch | |
| Abridged model | 31/12/2007 | 10/06/2008 | 28/08/2008 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
| Director | Function | Mandate |
|---|---|---|
Axel Derwa | Director |
Ended mandates
| Director | Function | Mandate |
|---|---|---|
Axel Derwa | Manager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates17/10/2023WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Capital / shares09/11/2018KAPITAAL - AANDELEN
- Capital / shares13/02/2014KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Registered office29/10/2010MAATSCHAPPELIJKE ZETEL
- Other09/02/2007RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025181,7 k €↑
- 2024Annual accounts 2024115,1 k €↓
- 2023Annual accounts 2023124,1 k €↑
- 2023Name changeDR. AXEL DERWA
- 2022Annual accounts 202284,7 k €↓
- 2021Annual accounts 2021109,5 k €↓
- 2020Annual accounts 2020149,1 k €↑
- 2019Annual accounts 2019148,6 k €↓
- 2018Annual accounts 2018229,4 k €↑
- 2017Annual accounts 201795,1 k €↓
- 2016Annual accounts 2016102,8 k €↓
- 2015Annual accounts 2015110,9 k €↑
- 2014Annual accounts 2014110,3 k €↑
- 2013Annual accounts 201324,9 k €↓
- 2012Annual accounts 2012225,4 k €↑
- 2011Annual accounts 2011127,2 k €↓
- 2010Annual accounts 2010149,8 k €↑
- 2009Annual accounts 2009105,5 k €↑
- 2008Annual accounts 200879 k €↑
- 2007Annual accounts 200740,8 k €
- 22/01/2007IncorporationPrivate limited company
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Konijnenpijp(LIN) 4, 3210 LubbeekCurrent | CBE, tracked since 27/09/2026 | CBE |
| KONIJNENPIJP 4, 3210 Lubbeek | accounts 2022 → 2025 | Accounts 2025 · 2026-00478708 |
| Konijnenpijp 4 4, 3210 Lubbeek | accounts 2021 | Accounts 2021 · 2022-20315655 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr. Axel DERWA, inwendige geneeskundeCurrent | CBE, tracked since 27/09/2026 | CBE |
| DR. AXEL DERWA | accounts 2023 → 2025 | Accounts 2025 · 2026-00478708 |
| Dr. Axel Derwa, Inwendige geneeskunde | accounts 2021 → 2022 | Accounts 2022 · 2023-00459273 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.